Statisilcal Methods
In the control group, the effects of gender on analyte activities were studied by testing the equality of means by Student's t-test. Homogeneity of within-subject variances in subgroups were tested by calculating the index of heterogeneity as recommended by Fraser and Harris (22). The index of heterogeneity is the ratio of the observed CV of a set of individual variances to the theoretical CV, which is [2/(n -1)], where n is the mean number of specimens collected per subject (22) . The reference change values for different enzymes were formed by subtracting the first result from the second result. The 2 SD limits of the distributions of changes of consecutive results were taken as the reference change limits as described elsewhere (9).
Calculation of the reference change limits from the actual patients' data was similar, except that the distributions of the changes were "mixed," containing -20-40% of data from patients with MI in the unselected group and probably some misclassified results, even in the diagnosis-selected group. However, because observed change in serial cardiac enzyme data is a most sensitive indicator of MI, the central part around the mode of the distribution of changes was expected to consist mostly of non-MI patients. For the non-MI patients, the variation in serial results was due to changes in preanalytical factors and random biological and analytical variation. Consequently, the distribution of the changes of the major non-MI subpopulation of patients was expected to approach a gaussian distribution.
The following statistical procedures were necessary for the resolution of the mixed distribution of changes: was subtracted from the total within-subject variance as described elsewhere (23) to get an estimate for within-subject biological variance.
The Statistical Analysis System#{174} (SAS Institute, Inc., Cary, NC) and Lotus 1-2-3#{174} (Lotus Development Corp., Cambridge, MA) software packages on microcomputer were used for the data analysis. A Lotus 1-2-3 macro subroutine that performed the calculations described in the Appendix was written by and is available from the first author.
Results
The t-test of means in the control group of 29 patients did not show any significant effects of gender on CK-2, U), or LD-1. For CK the association of male gender with higher levels of CK activity seemed possible but not statistically significant (P = 0.08). Consequently, gender subgrouping was not considered necessary.
To study variation of within-subject Figure 1C . In the diagnosis-selected and unselected patient groups, the within-subject variances were clearly heterogeneous, with indices of heterogeneity >3 for all analytes. The distributions of changes between two consecutive measurements were 5imilnr. In the diagnosis-selected patient group the distributions had short tails and the overall fit to gaiissic Table 2 , together with a review of previously published data.
Clinical sensitivity of the proposed reference change limits derived from selected patients' data was evaluated in the retrospective database with reference to cmical discharge diagnoses. Of the total of 576 patients Given reference change limitsare the ±2 SD limitsof either the original distribution of changes (control subjects) or the mathematically derived distribution of changes (patientsdata). 
DiscussIon
As noted by Fraser and Harris, the simple use of the distribution of changes for the calculation of reference change limits is justified when the within-subject variances are not heterogeneous (22) . By using their proposed index of heterogeneity, we could show that the within-subject variances of the control subjects in our study were homogeneous. In the unselected patient data, in which part of the patients had MI, the withinsubject variances were heterogeneous. The within-subject variances were clearly heterogeneous even in the diagnosis-selected group. This may be due to the release of small amounts of enzymes from slightly damaged myocardial tissue in a proportion of the diagnosis-selected non-MI patients, especially in those with unstable angina. The presence of microinfarcts in some angina patients has been verified by new sensitive methods for CK-2 mass concentration and troponin-T (24, 25). Another explanation for the heterogeneity could be the previously noted difficulties in using discharge diagnoses for the selection of reference subjects (17) (18) (19) . In our statistical method the main assumption was that the within-subject variances would be homogeneous in the major subpopulation of patients with no myocardial Ian1age. In such a subpopu]ation the distribution of changes would be symmetric and approach a gaussian distribution, thereby facilitating the use of the mathematical method to extract this distribution from the total distribution of changes. As shown in Table 1 , the calculated reference change limits from different sources of data were quite 5imilRr. Similnr results both from the unselected and diagnosisselected groups show that sickness-related change values do not much disturb the performance of the method as long as the health-related change values form the majority. The largest difference found was between control patients and unselected patients for the positive reference change limits of LD-1. Large numbers of sickness-related change values that overlap health-related change values in the group of unselected patients could affect the estimate for standard deviation of the underlying distribution and hence the estimates of reference change limits. Therefore, all available information should be used to ascertain that the proportion of sickness-related change values is as minims%1as possible before applying the statistical method.
Harris and Yasaka (7) defined reference change as "that difference between two consecutive test results in an individual that is statistically significant in a given proportion of all similar persons." To deal with the variation in within-subject variances, Harris and Yasaka used an autoregressive time-series model. They calculated the reference change limits representing that difference between two consecutive measurements that was expected by chance no more than 5% of the time in 88% of the healthy subjects. Their approach should be used if heterogeneity in within-subject variances is observed.
Several investigators
have published estimates for within-subject biological variation of cardiac enzymes.
Theoretically,
we could have calculated the reference change limits by using these data and the available data of analytical imprecision in our laboratory. However, as shown in Table 2 , there is considerable variation between different published data. This variation may reflect the difficulty in separating true biological variation from all other preanalytical sources of variation. Without any further investigations it would be difficult to decide which of the published data would apply to our patients and our preanalytical standards. Therefore, methods involving routine patients' data could be of significant help for computerized laboratories in the production of clinically applicable reference change limits.
The clinical importance of the evaluation of changes between consecutive cardiac enzyme results has been pointed out in previous studies (4, 32). Biodeau et al. (33) described a case history of a patient whose MI was diagnosed by observing the changes in serial cardiac enzyme results, although the activities never exceeded the upper reference limits. We evaluated the clinical utility of the reference change limits in our retrospective database of 2029 patients. The clinical sensitivity of a diagnostic rule "at least one change outside reference change limits" was at the same level as that of a diagnostic rule "at least one enzyme activity result above reference interval," 97.0% vs 97.9%. The value of this retrospective evaluation was reduced by the fact that the enzyme results had been available for the clinicians when they had given the diagnoses.
Ordinary reference limits were available as well, but the reference change limits were not. Unbiased estimation of clinical sensitivities and specificities of reference change limits would require prospective studies and a classification of patients that does not rely on enzyme results.
The lack of any statistically significant differences between the distributions of changes of control subjects and the mathematically produced distributions from actual patients' data suggests that it is possible to produce clinically applicable reference change limits from patients' data. The method presented could also be applied to other analytes that are used for monitoring patients, provided that only a minority of the patients actually develop the disease and that the within-subject van- 
AppendIx
Changes between consecutive enzyme results were calculated by subtracting the first result from the second result.
Estimation of Optimal Window Widths
Frequency grouping of the change value data by using optimal window widths was necessary for the precise estimation of the modal change. We calculated optimal window widths with the formula (34)
where W = optimal window width, A = min(s, RI1.34), 8 is the estimate of standard deviation, and n is the number of patients. R = -Q1, where 3 is the limit between the third and fourth quartile and 1 is the limit between the first and second quartile. These values were calculated after exclusion of outlying results. We used a simple rule to iteratively exclude all results that lay outside the ±4 SD limits of the mean (35). After each pass the new mean and new ±4 SD limits were recalculated and the process was repeated as many times as was necessary to end up in a situation that all results were inside the ±4 SD limits. The calculated window width was rounded to the next upper multiple of the original class width to facilitate frequency grouping of the data.
Estimation of the Mode
Information of the mode class and the two adjacent 
